Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral tizanidine for prolongation of sensory block during orthopedic surgery under spinal anesthesia
IRCT201610104780N10Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tizanidine, sponsored by Mashhad University of Medical Sciences. Primary endpoint: Duration of sensory block. Started Oct 2016; status: completed.
02
Drugs
tizanidine
Beyond the preview
Go deeper on IRCT201610104780N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201610104780N10.